Aberdeen Asset Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
Aberdeen Asset Management's AGN Position: Q2 2017 in Review
Aberdeen Asset Management increased its Allergan plc (AGN) stake by 3.5% in Q2 2017, buying an estimated $1.08M and bringing the position to 136,209 shares worth $33.1M. The position accounts for 0.11% of the portfolio, ranked #174.
Aberdeen Asset Management first reported a position in AGN in Q2 2013 and has held it in 17 quarters since. The position peaked at $49.6M in Q4 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.
- Aberdeen Asset Management held 136,209 shares of Allergan plc worth $33.1M as of Q2 2017.
- Aberdeen Asset Management bought 4,611 Allergan plc shares in Q2 2017, an estimated $1.08M.
- Allergan plc made up 0.11% of Aberdeen Asset Management's portfolio in Q2 2017, its #174 holding.
- Aberdeen Asset Management first reported a position in Allergan plc in Q2 2013 and has held it in 17 quarters since.
- Aberdeen Asset Management's Allergan plc position peaked at $49.6M in Q4 2015.
- 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.
Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.